{Reference Type}: Case Reports
{Title}: Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report.
{Author}: Calogiuri G;Foti C;Congedo M;Nettis E;Paladini L;Greco G;Pavone V;Vacca A;
{Journal}: Endocr Metab Immune Disord Drug Targets
{Volume}: 24
{Issue}: 4
{Year}: 2024 Oct 10
{Factor}: 2.387
{DOI}: 10.2174/0118715303241179230927105454
{Abstract}: <B>BACKGROUND: </B>Hereby, we describe the first case of latent mastocytosis triggered by mRNA-based vaccine to prevent COVID-19 infection.<BR><B>METHODS: </B>In a 42-year-old Arabian man affected by slight, undiagnosed mastocytosis, the second dose of the COVID-19 vaccine made more blatant his latent disease. The postvaccination diagnostic iter is illustrated and the potential reasons causing the onset of the cutaneous mastocytosis are discussed.<BR><B>CONCLUSIONS: </B>Clinicians should keep a longer follow-up of their patients after the COVID-19 vaccination, not related to few hours, for the risk of immediate-type adverse events only.